In patients with lung cancer, cold atmospheric plasma (CAP) enhances the interaction between HOXB9 and the acetyltransferase P300/CBP-associated factor (PCAF), thereby increasing the level of K27 acetylation on HOXB9. The gene discussed is HOXB9; the disease is lung carcinoma.